FLSM
Frazier Life Sciences Management Portfolio holdings
AUM
$2.5B
This Quarter Return
-9.64%
1 Year Return
+52.94%
3 Year Return
+530.54%
5 Year Return
–
10 Year Return
–
AUM
$1.17B
AUM Growth
–
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
60.23%
Holding
42
New
42
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Arcutis Biotherapeutics
ARQT
|
$162M |
| 2 |
Phathom Pharmaceuticals
PHAT
|
$79.3M |
| 3 |
Mirum Pharmaceuticals
MIRM
|
$78.5M |
| 4 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$75.1M |
| 5 |
Krystal Biotech
KRYS
|
$57.6M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 98.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Arcutis Biotherapeutics
ARQT
$1.86B
| $162M | 13.84% | +8,434,232 | New | +$162M |
|
|
2
Phathom Pharmaceuticals
PHAT
$864M
| $79.3M | 6.76% | +5,827,415 | New | +$79.3M |
|
|
3
Mirum Pharmaceuticals
MIRM
$3.71B
| $78.5M | 6.69% | +3,566,912 | New | +$78.5M |
|
|
SRRA
4
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $75.1M | 6.4% | +2,342,198 | New | +$75.1M |
|
|
5
Krystal Biotech
KRYS
$4.27B
| $57.6M | 4.91% | +866,250 | New | +$57.6M |
|
|
IMGO
6
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $57.3M | 4.88% | +2,971,274 | New | +$57.3M |
|
7
Vaxcyte
PCVX
$4B
| $55.8M | 4.75% | +2,309,554 | New | +$55.8M |
|
8
Syndax Pharmaceuticals
SNDX
$1.41B
| $55.5M | 4.73% | +3,195,403 | New | +$55.5M |
|
|
KDNY
9
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $44.4M | 3.78% | +2,712,041 | New | +$44.4M |
|
|
ISEE
10
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $40.8M | 3.47% | +2,421,563 | New | +$40.8M |
|
|
ALPN
11
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $37.5M | 3.2% | +4,185,757 | New | +$37.5M |
|
12
Viridian Therapeutics
VRDN
$1.5B
| $32.2M | 2.74% | +1,739,530 | New | +$32.2M |
|
13
Crinetics Pharmaceuticals
CRNX
$2.92B
| $31.1M | 2.65% | +1,414,823 | New | +$31.1M |
|
|
BCYC
14
Bicycle Therapeutics
BCYC
$511M
| $26.5M | 2.26% | +603,521 | New | +$26.5M |
|
15
Tarsus Pharmaceuticals
TARS
$2.47B
| $23.8M | 2.03% | +1,417,157 | New | +$23.8M |
|
16
KalVista Pharmaceuticals
KALV
$678M
| $23.2M | 1.98% | +1,572,192 | New | +$23.2M |
|
17
AnaptysBio
ANAB
$569M
| $22.3M | 1.9% | +899,700 | New | +$22.3M |
|
|
GRTS
18
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $21.6M | 1.84% | +5,237,348 | New | +$21.6M |
|
19
Cogent Biosciences
COGT
$1.69B
| $19.9M | 1.69% | +2,651,754 | New | +$19.9M |
|
20
Arvinas
ARVN
$568M
| $18.2M | 1.55% | +270,331 | New | +$18.2M |
|
|
TCDA
21
DELISTED
Tricida, Inc. Common Stock
TCDA
| $17.1M | 1.46% | +2,082,093 | New | +$17.1M |
|
|
SLN
22
Silence Therapeutics
SLN
$227M
| $16.7M | 1.43% | +881,173 | New | +$16.7M |
|
23
Merus
MRUS
$4.98B
| $16.6M | 1.42% | +628,979 | New | +$16.6M |
|
|
AUTL
24
Autolus Therapeutics
AUTL
$399M
| $15.6M | 1.33% | +3,746,857 | New | +$15.6M |
|
25
Passage Bio
PASG
$22.7M
| $15.5M | 1.32% | +5,009,219 | New | +$15.5M |
|